Prasse et al. demonstrated that alternative activated macrophages trigger a vicious circle between alveolar macrophages and fibroblasts by releasing IL10, IL1 receptor antagonist, and CCL18 (also named PARC or MIP-4), which promote collagen deposition and fibrotic progression of IPF [9]. The gene discussed is CCL18; the disease is idiopathic pulmonary fibrosis.